A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate damaged p53. This vital cancer inhibitor protein is frequently disabled in several forms of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research